期刊文献+

HER3高表达与胃癌恶性表型的关系 被引量:1

Relationship between overexpression of HER3 and malignant phenotype of gastric cancer
原文传递
导出
摘要 目的探讨人表皮生长因子受体3(HER3)在人胃癌组织及胃癌细胞株中的表达。方法回顾性分析胃癌患者161例,应用免疫组化方法分析HER3表达。构建针对人HER3基因的小干扰RNA(siRNA),对HER3高表达的胃癌细胞株进行转染,检测转染前后胃癌细胞株增殖、迁移率、凋亡率变化。结果 HER3高表达与肿瘤浸润深度、淋巴结转移、分期、神经脉管侵犯及预后有关(P<0.05或P<0.01)。多因素分析显示:肿瘤分期(HR:4.044,95%CI:2.149-7.609,P=0.000)、HER3高表达是胃癌独立的预后因素(HR:1.922,95%CI:1.081-3.416,P=0.026)。HER3siRNA处理胃癌细胞株后,HER3表达下调,胃癌细胞株增殖(72h时,MNK45vs.MNK45siRNA,SGC7901vs.SGC7901siRNA:P<0.05;96h时,MNK45vs.MNK45siRNA:P<0.05,SGC7901vs.SGC7901siRNA:P<0.01)、迁移受抑制(P=0.0071),凋亡增加(MNK45vs.MNK45siRNA:P=0.0019;SGC7901vs.SGC7901siRNA:P=0.0061)。结论 HER3与胃癌恶性表型密切相关,是胃癌预后不良的独立指标之一,有可能成为治疗新靶点。 Objective To study the relationship between overexpression of human epidermal growth factor receptor 3(HER3) and malignant phenotype of gastric cancer. Methods The expression of HER3 was detected by irmnunohistochemistry in 161 patients with gastric cancer underwent gastrectomy. Clinicopathological characteristics and the expression of HER3 were retrospectively analyzed. HER3 siRNA was constructed and transfected to human gastric cancer cell with HER3 expression. The expression of HER3 was detected by Western blot assay, the proliferation of the cells by MTT assay, the invasion by wound-healing assay, and the apoptosis by TUNEL assay. Results The high expression of HER3 was associated with tumor invasive depth, lymph node metastasis, stage,the invasion of nerve and vessel, and the 4-year overall survival(P〈0.05 or P〈0. 01). The independent prognostic factors were the stage (HR.. 4. 044, 95% CI: 2. 149-7. 609, P=0. 000) and overexpression of HER3(HR: 1. 922,95%CI: 1. 081-3. 416, P=0. 026). In vitro, expression of HER3 was significantly inhibited by HER3 siRNA. The proliferation(72 h: MNK45 vs. MNK45 siRNA, SCK;7901 vs. SGC7901 siRNA: P〈0. 05,96 h: MNK45 vs. MNK45 siRNA: P〈0. 05, SGC7901 vs. 8GC7901 siRNA: P〈0.01) and the invasion (P=0.0071) of gastric cancer cells were down- regulated and the apoptosis(MNK45 vs. MNK45 siRNA: P=0. 0019,SGC7901 vs. SCC7901 siRNA: P=0. 0061) of the cells was significantly increased after treated with HER3 siRNA. Conclusion In gastric cancer, the overexpression of HER3 is associated with the proliferation, invasion, and apoptosis of gastric cancer. High expression of HER3 predicts a poor survival in the patients with gastriccancer.
出处 《江苏医药》 CAS 北大核心 2013年第1期17-20,共4页 Jiangsu Medical Journal
基金 国家自然科学基金青年科学基金项目(81201797) 江苏省社会发展科技计划项目基金(BS2007010) 江苏省自然科学基金(BK2009445) 江苏省"六大人才高峰"项目(2009-D-63) 江苏省卫生厅青年科研项目(H201065)
关键词 胃癌 人表皮生长因子受体3 Gastric cancer Human epidermalgrowth factor receptor 3
  • 相关文献

参考文献12

  • 1Hayashi M,lnokuchi M,Takagi Y,et al. High expression ofHER3 is associated with a decreased survival in gastric cancer[J]. Clin Cancer Res,2008,14(23) :7843- 7849.
  • 2Begnami MD?Fukuda E,Fregnani JH?et al. Prognostic impli-cations of altered human epidermal growth factor receptors(HERs) in gastric carcinomas: HER2 and HER3 arepredictors of poor outcome[J]. J Clin Oncol,2011,29 (22):3030- 3036.
  • 3Tzahar E,Waterman H, Chen X,et al. A hierarchicalnetwork of inter-receptor interactions determines signaltransduction by Neu differentiation factor/neuregulin andepidermal growth factor [j]. Mol Cell Biol, 1996,16(10):5276- 5287.
  • 4Holbro T,Beerli RR, Maurer F,et al. The ErbB2/ErbB3heterodimer functions as an oncogenic unit: ErbB2 requiresErbB3 to drive breast tumor cell proliferation[J]. Proc NatlAcad Sci U S A,2003,100(15);8933- 8938.
  • 5范伯强,宋国新,张炜明,王榕生,刘凌翔,束永前.HER2和HER3在胃癌中表达的临床意义[J].江苏医药,2010,36(23):2777-2780. 被引量:8
  • 6Tanner B,Hasenclever D, Stern K,et al. ErbB-3 predictssurvival in ovarian cancer [J]. J Clin Oncol, 2006, 24 (26):4317- 4323.
  • 7Reschke M,Mihic-Probst D,van der Horst EH,et al. HER3is a determinant for poor prognosis in melanoma [J]. ClinCancer Res,2008,14(16) : 5188- 5197.
  • 8葛棣,郑如恒,曾亮,冯明祥.HER3在食管癌中表达的临床意义[J].胃肠病学,2003,8(3):148-150. 被引量:5
  • 9司品现,杨渝浩,董德琼,孙显明,姚红梅.C-erbB-3/HER3在肺鳞状细胞癌中的表达及意义[J].贵州医药,2001,25(9):786-788. 被引量:3
  • 10Sun Behrens C, Feng L,et al. HER family receptorabnormalities in lung cancer brain metastases andcorresponding primary tumors[J]. Clin Cancer Res,2009,15(15)-.4829- 4837.

二级参考文献30

  • 1Hynes NE, Lane HA. ERBB receptors and cancer: the com- plexity of targeted inhibitors[J]. Nat Rev Cancer, 2005, 5 (5) :341-354.
  • 2Baselga J, Swain SM. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3[J]. Nat Rev Cancer, 2009,9 (7):463-475.
  • 3Gravalos C,Jimeno A. HELL2 in gastric cancer: a new prog- nostic factor and a novel therapeutic target[J]. Ann Oncol, 2008,19(9): 1523-1529.
  • 4Hayashi M, Inokuchi M, Takagi Y, et al. High expression of HER3 is associated with a decreased survival in gastric cancer [J]. Clin Cancer Res,2008,14(23) :7843-7849.
  • 5Zhang XL, Yang YS, Xu DP, et al. Comparative study on overexpression of HER2/neu and HER3 in gastric cancer[J]. World J Surg,2009,33(10) :2112-2118.
  • 6Catalano V,Labianca R,Beretta GD,et al. Gastric cancer[J]. Crit Rev Oncol Hematol, 2009, 71 (2) : 127-164.
  • 7Gazdar AF. Epidermal growth factor receptor inhibition in lung cancer.-the evolving role of individualized therapy[J]. Cancer Metastasis Rev, 2010,29(1) : 37-48.
  • 8Murphy CG, Modi S. HER2 breast cancer therapies: a review [J]. Biologics, 2009,3: 289-301.
  • 9Van Cutsem E, Kang Y, Chung H, et al. Efficacy results from the ToGA trial: a phase Ⅲ study of trastuzumab added to standard chemotherapy (CT) in first-line human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer[J]. J Clin Oncol,2009,27(Suppl):18s.
  • 10Hede K. Gastric cancer: trastuzumab trial results spur search for other targets [J ]. J Natl Cancer Inst, 2009, 101 ( 19 ) : 1306-1307.

共引文献13

同被引文献11

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部